Federal contract award

75F40123F19001

COMPARATIVE USE HUMAN FACTORS STUDY TO ASSESS WHETHER CERTAIN USER INTERFACE DIFFERENCES BETWEEN PEN-INJECTOR COMBINATION PRODUCTS AFFECT USER ERROR RATES AMONG DIABETIC PATIENTS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541720 — Research and Development in the Social Sciences and Humanities
PSCB599 — Other Special Studies and Analysis
Parent award / vehicle75F40123D00028
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$404.1K
Current contract value$404.1K
Potential contract value / ceiling$404.1K
Start dateSep 28, 2023
Current end dateSep 29, 2025
Potential end dateSep 29, 2025
Latest award activityDec 5, 2024
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Dec 5, 2024P00003$0COMPARATIVE USE HUMAN FACTORS STUDY TO ASSESS WHETHER CERTAIN USER INTERFACE DIFFERENCES BETWEEN PEN-INJECTOR COMBINATION PRODUCTS AFFECT USER ERROR RATES AMONG DIABETIC PATIENTS
Aug 20, 2024P00002$209.1KCOMPARATIVE USE HUMAN FACTORS STUDY TO ASSESS WHETHER CERTAIN USER INTERFACE DIFFERENCES BETWEEN PEN-INJECTOR COMBINATION PRODUCTS AFFECT USER ERROR RATES AMONG DIABETIC PATIENTS
Oct 16, 2023P00001$0COMPARATIVE USE HUMAN FACTORS STUDY TO ASSESS WHETHER CERTAIN USER INTERFACE DIFFERENCES BETWEEN PEN-INJECTOR COMBINATION PRODUCTS AFFECT USER ERROR RATES AMONG DIABETIC PATIENTS
Sep 28, 20230$195.0KCOMPARATIVE USE HUMAN FACTORS STUDY TO ASSESS WHETHER CERTAIN USER INTERFACE DIFFERENCES BETWEEN PEN-INJECTOR COMBINATION PRODUCTS AFFECT USER ERROR RATES AMONG DIABETIC PATIENTS

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.